| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.28 |
0.3 |
| mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.25 |
0.4 |
| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.22 |
0.5 |
| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.2 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.2 |
| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.04 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.006 |
| mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.1 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |